| 英文别名 |
Despropyl Macitentan;N-Despropyl-macitentan;ACT132577;N-[5-(4-Bromophenyl)-6-[2-[(5-bromo-2-pyrimidinyl)oxy]ethoxy]-4-pyrimidinyl]sulfamide;Aprocitentan;BRD-K34843150-001-02-2;Aprocitentan (ACT-132577);ACT 132577;CHEMBL2165326;Tryvio;Macitentan metabolite m6;D11441;Q27146161;5-(4-bromophenyl)-6-[2-(5-bromopyrimidin-2-yl)oxyethoxy]-N-(sulfamoyl)pyrimidin-4-amine;N-(5-(4-BROMOPHENYL)-6-(2-((5-BROMO-2-PYRIMIDINYL)OXY)ETHOXY)-4-PYRIMIDINYL)-SULFAMIDE;AS-82256;N-[5-(4-bromophenyl)-6-{2-[(5-bromopyrimidin-2-yl)oxy]ethoxy}pyrimidin-4-yl]sulfuric diamide;SCHEMBL3646065;DB15059;D87138;N-Despropyl Macitentan;Sulfamide, N-(5-(4-bromophenyl)-6-(2-((5-bromo-2-pyrimidinyl)oxy)ethoxy)-4-pyrimidinyl)-;BRD-K34843150-001-01-4;[5-(4-Bromophenyl)-6-[2-[(5-bromo-2-pyrimidinyl)oxy]-ethoxy]-4-pyrimidinyl]sulfamide;MZI81HV01P;N-(5-(4-BROMOPHENYL)-6-(2-((5-BROMOPYRIMIDIN-2-YL)OXY)ETHOXY)PYRIMIDIN-4-YL)SULFAMIDE;BDBM50395672;MFCD28155267;UNII-MZI81HV01P;GTPL10070;Aprocitentan [WHO-DD];APROCITENTAN [INN];Aprocitentan [USAN];WHO 10552;N-(5-(4-Bromophenyl)-6-(2-((5-bromo-2-pyrimidinyl)oxy)ethoxy)-4-pyrimidinyl)sulfuric diamide;Aprocitentan (ACT-132577)?;Tryvio (TN);5-(4-bromophenyl)-4-[2-(5-bromopyrimidin-2-yl)oxyethoxy]-6-(sulfamoylamino)pyrimidine;N-[5-(4-Bromophenyl)-6-[2-[(5-bromo-2-pyrimidinyl)oxy]ethoxy]-4-pyrimidinyl]-sulfamide, ACT-132577;NCGC00378592-01;BCP28125;SY310435;ACT-132577; ACT 132577; ACT132577;DB-130379;CHEBI:76609;Aprocitentan (USAN/INN);HY-15895;EX-A4419;ACT-132577;AC-36529;1103522-45-7;XH1600;AKOS028114466 |